Amid Global Setbacks, Indian Pharma Exports Grow In 2021-22.

The Government of India recently announced that the pharmaceutical sector had its best-ever export performance in 2021-22, with a phenomenal increase of about $10 billion in just eight years.

Thermo Fisher, Charles River Join Forces With Multiply Labs.

Multiply Labs is equipping itself with two additional pieces of industry-leading tech in its quest to automate manual elements of the cell therapy production process. The new kit arrives little over...

Collaborating to Provide Development & Manufacturing Services for Biotech Firms.

Lonza and ALSA Ventures Colloboration: ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries...

Sanofi Drug Ingredients Startup Takes off After Two Years.

It's a fact: EUROAPI debuted on the Euronext exchange two years and one pandemic after Sanofi announced plans to sell off its European pharma ingredients division. Even though the market...

Novartis Halts Cancer Radiotherapy Output Due To Quality.

Novartis has halted production of its two commercial radioligand treatments for cancer care just weeks after the FDA approved them.Novartis confirmed on May 5th that production of Lutathera, a neuroendocrine...

In Preserved Ejection Fraction Trial Farxiga Shows Depth.

DELIVER is the world's largest study of heart failure with intact ejection fraction. The DELIVER phase 3 trial produced favourable findings for AstraZeneca. It showed that Farxiga reduced...

Moderna Fine Tweaks Its Booster Prior To The Fall Season.

The question is whether to boost or not to boost. The answer is a resounding yes, as per officials at mRNA expert Moderna. Moderna's chief medical officer, Paul Burton, M.D., Ph.D., stated that the SARS-CoV-2...

FDA Stalls The Use of J&J COVID Jab Due To Thrombosis Risk.

The US Food and Drug Administration recently announced that the Johnson & Johnson/Janssen COVID-19 vaccine's urgent use permit will be restricted to people 18 or older for whom other vaccines are really not suitable or available...

FDA Officials Say They Will Need COVID Jabs In The Future.

According to a trio of prominent US FDA experts, the US may need to update its COVID-19 vaccines every year, and a new normal may comprise a yearly vaccine alongside a seasonal flu shot.